Medidata Solutions Stock Rating Reaffirmed by Topeka Capital Markets (MDSO)
Medidata Solutions (NASDAQ:MDSO)‘s stock had its “buy” rating restated by research analysts at Topeka Capital Markets in a report released on Wednesday. They currently have a $50.00 target price on the stock, up from their previous target price of $49.00. Topeka Capital Markets’ price objective points to a potential upside of 6.54% from the stock’s previous close.
Shares of Medidata Solutions (NASDAQ:MDSO) traded up 4.10% during mid-day trading on Wednesday, hitting $46.93. 901,481 shares of the company’s stock traded hands. Medidata Solutions has a 52 week low of $32.10 and a 52 week high of $68.21. The stock’s 50-day moving average is $41.21 and its 200-day moving average is $49.10. The company has a market cap of $2.454 billion and a P/E ratio of 257.60.
Medidata Solutions (NASDAQ:MDSO) last released its earnings data on Tuesday, July 29th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by $0.01. The company had revenue of $83.20 million for the quarter, compared to the consensus estimate of $81.90 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The company’s revenue for the quarter was up 22.2% on a year-over-year basis. On average, analysts predict that Medidata Solutions will post $0.76 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group raised their price target on shares of Medidata Solutions from $50.00 to $53.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Stifel Nicolaus initiated coverage on shares of Medidata Solutions in a research note on Tuesday, June 17th. They set a “buy” rating and a $47.00 price target on the stock. Finally, analysts at Stifel Nicolaus initiated coverage on shares of Medidata Solutions in a research note on Tuesday, June 17th. They set a “buy” rating and a $47.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $57.70.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.